2739-0127 Screening compound: 2-{3-[(furan-2-yl)methyl]-5-oxo-1-(2-phenylethyl)-2-sulfanylideneimidazolidin-4-yl}-N-phenylacetamide

2739-0127 Screening compound: 2-{3-[(furan-2-yl)methyl]-5-oxo-1-(2-phenylethyl)-2-sulfanylideneimidazolidin-4-yl}-N-phenylacetamide
2739-0127 Screening compound: 2-{3-[(furan-2-yl)methyl]-5-oxo-1-(2-phenylethyl)-2-sulfanylideneimidazolidin-4-yl}-N-phenylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 2739-0127
2-{3-[(furan-2-yl)methyl]-5-oxo-1-(2-phenylethyl)-2-sulfanylideneimidazolidin-4-yl}-N-phenylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

2739-0127

Molecular Formula

C24H23N3O3S (C24 H23 N3 O3 S)

Compound Name

2-{3-[(furan-2-yl)methyl]-5-oxo-1-(2-phenylethyl)-2-sulfanylideneimidazolidin-4-yl}-N-phenylacetamide

IUPAC name

2-{3-[(furan-2-yl)methyl]-5-oxo-1-(2-phenylethyl)-2-sulfanylideneimidazolidin-4-yl}-N-phenylacetamide

SMILES

O=C(CC(C(N1CCc2ccccc2)=O)N(Cc2ccco2)C1=S)Nc1ccccc1

InChI

InChI=1S/C24H23N3O3S/c28-22(25-19-10-5-2-6-11-19)16-21-23(29)26(14-13-18-8-3-1-4-9-18)24(31)27(21)17-20-12-7-15-30-20/h1-12,15,21H,13-14,16-17H2,(H,25,28)/t21-/m1/s1

InChI Key

VRUDSIRVDZGBOL-OAQYLSRUSA-N

MDL Number (MFCD)

MFCD03916367

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

433.53

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.500

Distribution Coefficient, logD

3.500

Water Solubility, LogSw

-3.73

Polar Surface Area

49.736

Acid Dissociation Constant (pKa)

12.18

Base Dissociation Constant (pKb)

0.51

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

20.80

2739-0127 in Drug Discovery

Included in Screening Libraries

Anti-HIV1 Library (19540 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system

References: we are preparing a list of scientific research reports with 2739-0127 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 2739-0127?
Check Price and Availability of 2739-0127, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 2739-0127 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 2739-0127
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 2739-0127
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 2739-0127 available by request